Holen Sie sich die Stockscreener-App
395.15
2.02%
7.83
Vorhandelsmarkt:
395.01
-0.14
-0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$387.32
Offen:
$389.62
24-Stunden-Volumen:
1.02M
Relative Volume:
0.81
Marktkapitalisierung:
$150.82B
Einnahmen:
$23.22B
Nettoeinkommen (Verlust:
$2.86B
KGV:
53.40
EPS:
7.4
Netto-Cashflow:
$3.58B
1W Leistung:
+1.17%
1M Leistung:
+5.22%
6M Leistung:
+1.19%
1J Leistung:
+15.41%
1-Tages-Spanne:
$389.52
$395.70
1-Wochen-Bereich:
$385.19
$395.70
52-Wochen-Spanne:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Vergleichen Sie SYK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
What drives Stryker Corporation stock priceRapidly expanding wealth - jammulinksnews.com
Stryker Corporation Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com
What analysts say about Stryker Corporation stockFree Wealth Planning Blueprint - jammulinksnews.com
Lobbying Update: $230,000 of STRYKER CORPORATION lobbying was just disclosed - Nasdaq
Stryker Corporation's (NYSE:SYK) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - 富途牛牛
ISRG vs. SYK: Which Robotic Surgery Stock Is the Stronger Buy Today? - Yahoo Finance
Stryker's Consistent Growth and Market Positioning Justify Buy Rating - AInvest
Stryker Keeps Growing As Medical Device Demand Rises - Finimize
Rep. Thomas Kean Has Sold Up to $65K Worth Of Stryker Stock: Here's What You Should Know - Benzinga
David Driscoll discusses Stryker Corp - BNN Bloomberg
10 Best Health Care Stocks to Buy for 2025 | Investing - US News Money
Stryker (SYK) Faces New Competition in Robotics | SYK Stock News - GuruFocus
Stryker (SYK) Secures $450 Million Defense Contract Extension - GuruFocus
Stryker (SYK) Secures $450M Military Equipment Contract Extensio - GuruFocus
FDA Green Lights Stryker’s Incompass™ Total Ankle System - Orthopedics This Week
Stryker (SYK) Price Target Raised by BTIG Amid Mixed MedTech Sen - GuruFocus
What to Expect From Stryker's Next Quarterly Earnings Report - MSN
Looking Into Stryker's Recent Short Interest - 富途牛牛
North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key CompaniesOlympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies - Yahoo Finance
Blood Lead Analyzer Market Outlook 2025-2034 | Stryker Launches Advanced Pediatric ESIN Systems, Orthofix and Smith & Nephew Follow Suit - Yahoo Finance
What To Expect From Stryker's Next Quarterly Earnings Report - Barchart.com
Is Now The Time To Look At Buying Stryker Corporation (NYSE:SYK)? - 富途牛牛
Stryker’s Incompass System Secures FDA Nod, Boosting Orthopaedics Innovation Strategy - Yahoo Finance
Boston Scientific Sues Stryker Over Back Pain Treatment Patent - Bloomberg Law News
Here's How Much You Would Have Made Owning Stryker Stock In The Last 5 Years - Benzinga
Stryker to Report Second Quarter Fiscal Year 2025 Financial Results on July 31, 2025 - Quiver Quantitative
Stryker Earnings: When and How to Access Q2 2025 Financial Results and Live Webcast - Stock Titan
SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle System - Yahoo Finance
Stryker names Mike Carlin as leader of digital, robotics unit - Yahoo Finance
Ex-Dividend Reminder: National Healthcare, Stryker and Agree Realty - Nasdaq
Stryker makes leadership changes in digital, robotics business - MassDevice
Stryker receives FDA clearance for new total ankle replacement system - Investing.com
Moody’s upgrades Stryker Corporation to A3, outlook stable - Investing.com
Stryker Beats Sales Worker’s Military, Medical Leave Bias Claims - Bloomberg Law News
Stryker (SYK): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Stryker’s SWOT analysis: medical tech giant eyes growth amid challenges By Investing.com - Investing.com Canada
Stryker’s SWOT analysis: medical tech giant eyes growth amid challenges - Investing.com
These are West Michigan’s highest-paid CEOs at publicly traded companies - Crain's Grand Rapids Business
The Zacks Analyst Blog Highlights Mastercard, Verizon Communications, Stryker, Espey Mfg. & Electronics and Comstock Holding - Yahoo Finance
Top Analyst Reports for Mastercard, Verizon & Stryker - MSN
Is Stryker Stock Underperforming the Nasdaq? - MSN
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Surgical Booms Market Is Booming WorldwideStryker - openPR.com
Is Stryker Stock Underperforming The Nasdaq? - Barchart.com
Pressure Relief Devises Industry Overview: Innovations & Key - openPR.com
Stryker (SYK): Company Profile, Stock Price, News, Rankings - Fortune
Barclays maintains Stryker stock Overweight rating, $443 target By Investing.com - Investing.com South Africa
Barclays maintains Stryker stock Overweight rating, $443 target - Investing.com
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today - Benzinga
Stryker tops list of West Michigan’s largest publicly traded companies - Crain's Grand Rapids Business
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.60%
2.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):